News & Perspective

Dec 21, 2009

Dec 21, 2009

Study: One H1N1 vaccine dose may be OK for young children

(CIDRAP News) – A study in Australia showed that one dose of H1N1 influenza vaccine, rather than the two doses recommended in the United States, was enough to generate a probably protective immune response in children younger than 9 years.

Dec 18, 2009

Dec 18, 2009

States with widespread pandemic flu drop to 11

(CIDRAP News) – The second wave of the H1N1 influenza pandemic continued to fade last week, as the number of states with widespread cases dropped to 11 and reported deaths in children also declined, the Centers for Disease Control and Prevention (CDC) said today.

The CDC also reported finding 15 more cases of oseltamivir (Tamiflu)–resistant H1N1 viruses, but it said those instances remain rare.

Dec 17, 2009

Dec 17, 2009

Vaccine availability opens up as doses approach 100 million

(CIDRAP News) – The nation is reaching a new milestone in its fight against pandemic flu, with the number of vaccine doses expected to reach 100 million by the end of the week and nearly half of states opening up immunization to anyone who wants it, federal officials said today.

Dec 17, 2009

Three Asian countries top list to get donated H1N1 vaccine

(CIDRAP News) – Afghanistan, Azerbaijan, and Mongolia will be the first three countries to receive donated supplies of pandemic H1N1 vaccine funneled through the World Health Organization, the WHO announced today as it cautioned that it's too early to declare the pandemic over.

Dec 16, 2009

Dec 16, 2009

HHS urges continued H1N1 vaccination of health workers, everyone

(CIDRAP News) – Despite a dip in cases, H1N1 influenza has not gone away and could resurge, making continued vaccination critical, government and private health officials said today.

Speaking on a webcast for health care providers conducted by the Department of Heath and Human Services (HHS), the experts urged healthcare workers to take the vaccine themselves and to continue to push it out to patients.

Dec 16, 2009

Study shows adjuvant boosts response to H1N1 vaccine

(CIDRAP News) – Novartis's pandemic H1N1 flu vaccine generated stronger immune responses when it was combined with an adjuvant than when used alone, though both formulations yielded good results, according to a report published by the New England Journal of Medicine.

Pages

Sort Results

 

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»